Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ RGS22 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA534426
Description
A suggested positive control is Jurkat cell lysate. PA5-34426 can be used with blocking peptide PEP-1468.
Regulator of G-protein signaling (RGS) proteins contain an 120 amino acid conserved domain, termed the RGS domain, that acts as a GTPase-activating protein that acts to reduce the signal transmitted by the receptor-activated G-alpha subunit. RGS22 is a recently identified member of this family that localizes to the testis and can interact with guanine nucleotide binding proteins alpha 11, 12, and 13 (GNA11, GNA12, and GNA13). While RGS22 has been postulated to play a role in spermiogenesis in the testis, it is also expressed in several cancer cell lines with an epithelial origin and associated with cancer metastasis. Its overexpression in a highly metastatic cancer causes a decrease in cell migration and a reduction of the invasive potential of the cells, suggesting that RGS22 may be a potential prognostic biomarker for metastasis.
Specifications
RGS22 | |
Polyclonal | |
Unconjugated | |
RGS22 | |
CT145; PRTD-NY2; Regulator of G-protein signaling 22; regulator of G-protein signalling 22; RGD1565493; Rgs22 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
26166, 500853 | |
Maintain refrigerated at 2-8°C for up to 3 months. For long term storage store at -20°C | |
Liquid |
Immunohistochemistry, Western Blot | |
1 mg/mL | |
PBS with 0.02% sodium azide | |
Q8NE09 | |
RGS22 | |
A 19 amino acid synthetic peptide near the amino terminus of human RGS22. | |
100 μg | |
Primary | |
Human, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction